Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory efficacy of N-acetylcysteine in patients with history of COVID-19
2021-002825-10Phase 2Terminated
- Sponsor
- Policlinico Gemelli
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory failure, pneumonia and airway morbidity comparing N-acetylcysteine with Placebo (2 arms). Primary endpoint: Change in percent predicted DLco from baseline to week 12. Started Oct 2021; status: terminated.
02
Drugs
acetylcysteine
03
Conditions
respiratory failurepneumoniaairway morbidity
Beyond the preview
Go deeper on 2021-002825-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002825-10.